IDEAYA Biosciences announced plans for a public offering, expecting to raise up to 300 million dollars.

This issuance will include the company’s common shares and accompanying pre-financing warrants. The move aims to provide funding support for the company’s subsequent R&D activities and general operations. Specific terms of the issuance, including the number of shares to be issued, warrant terms, and final pricing, will be determined based on market conditions and other factors.